Whitehorse Finance, Inc. quarterly report, Q3 FY2013

Whitehorse Finance, Inc. - 10-Q Summary (Period Ended September 30, 2013)

Business Context and Reporting Period

Whitehorse Finance, Inc. is an externally managed, non-diversified, closed-end management investment company operating as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company focuses on originating and investing in senior secured loans to performing small-cap companies in North America. This report covers the quarterly period ended September 30, 2013, and the nine-month period ended on the same date. The company completed its IPO and conversion from an LLC to a corporation in December 2012.

Key Financial Metrics

Metric Three Months Ended Sep 30, 2013 Nine Months Ended Sep 30, 2013 As of Sep 30, 2013
Total Investment Income $11.1 million $29.0 million -
Net Investment Income $6.3 million $15.1 million -
Net Increase in Net Assets (Operations) $6.0 million $12.7 million -
Net Asset Value (NAV) per Share - - $15.09
Total Assets - - $353.1 million
Total Liabilities - - $127.1 million
Total Net Assets - - $226.0 million
Cash and Cash Equivalents - - $62.3 million (Unrestricted)
Restricted Cash - - $70.1 million
Outstanding Debt - - $85.0 million (Senior Notes + Term Loan)
Portfolio Fair Value - - $214.7 million
Weighted Average Cash Yield - - 12.2%

Material Changes vs. Prior Period

  • Debt Structure: The company significantly altered its capital structure. It issued $30.0 million in 6.50% Senior Notes due 2020 and used proceeds to reduce its Unsecured Term Loan from $90.0 million to $55.0 million. The Credit Facility was fully repaid, reducing outstanding borrowings from $51.3 million at year-end 2012 to $0.
  • Portfolio Composition: The investment portfolio grew from 8 positions ($180.5 million fair value) at December 31, 2012, to 17 positions ($214.7 million fair value) at September 30, 2013. The average investment size decreased from $22.7 million to $12.6 million.
  • Expenses: Operating expenses increased significantly compared to the prior year due to the implementation of the Investment Advisory Agreement and Administration Agreement post-IPO. Total expenses for the nine months ended September 30, 2013, were $13.9 million, compared to $0.4 million in the same period in 2012 (which had no management or interest fees).
  • Unrealized Gains/Losses: The company recorded a net unrealized depreciation of $2.4 million for the nine months ended September 30, 2013, contrasting with net unrealized appreciation of $5.4 million in the same period in 2012.

Guidance, Outlook, and Risks

  • Liquidity: The company maintains $132.4 million in total cash resources (including restricted cash). It has $150.0 million in undrawn capacity under its Credit Facility, with approximately $87.8 million available for drawdown based on collateral requirements.
  • Distributions: The company declared distributions of $0.355 per share for the quarter and $1.065 per share for the nine-month period. Management stated that distributions did not include a return of capital for tax purposes based on current earnings.
  • Interest Rate Risk: Approximately 83.7% of the portfolio consists of variable-rate investments indexed to LIBOR. Most floating-rate investments have interest rate floors, limiting downside risk but also capping upside benefit until rates exceed the floor.
  • Valuation Risks: All investments are classified as Level 3 fair value measurements, relying on unobservable inputs such as discounted cash flow models and market quotes. Valuations are subject to significant judgment and market uncertainty.
  • Related Party Transactions: The company pays a 2.0% base management fee and a performance-based incentive fee to its adviser, H.I.G. WhiteHorse Advisers, LLC. Related parties also hold co-investments in the portfolio.

Investor Verification Checklist

  • Debt Covenants: Verify compliance with asset coverage ratios (currently 365.9%) and leverage restrictions under the Credit Facility and Senior Notes indenture.
  • Portfolio Concentration: Review the top 5 portfolio holdings, which represent a significant portion of the fair value (e.g., Genoa Healthcare at 12.10% and GMT Holdings at 10.71%).
  • Valuation Methodology: Assess the sensitivity of Level 3 valuations to changes in discount rates, given the reliance on internal models for illiquid assets.
  • Reinvestment Capacity: Confirm the availability of the $87.8 million undrawn credit facility and the company's ability to deploy capital given the current pipeline of commitments ($0.3 million outstanding).
  • Expense Ratios: Monitor the total expense ratio (8.10% for the nine months ended Sep 30, 2013) and the impact of incentive fees on net investment income.